Aljo, Reizyl Jane D.

HRN: 23-94-36  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2024
CEFTRIAXONE 1G (VIAL)
10/12/2024
10/19/2024
IV
2g
OD
Uti
Waiting Final Action 
10/16/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/16/2024
10/23/2024
IV
4.5grams
Q 8hrs
Uti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: